HMG-CoA Reductase Inhibitors (Paperback, Softcover reprint of the original 1st ed. 2002)


HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume...

R2,916

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles29160
Mobicred@R273pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 10 - 15 working days


Toggle WishListAdd to wish list
Review this Item

Product Description

HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume...

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Springer Basel

Country of origin

Switzerland

Series

Milestones in Drug Therapy

Release date

October 2012

Availability

Expected to ship within 10 - 15 working days

First published

October 2012

Editors

,

Dimensions

235 x 155 x 8mm (L x W x T)

Format

Paperback

Pages

151

Edition

Softcover reprint of the original 1st ed. 2002

ISBN-13

978-3-03-489451-7

Barcode

9783034894517

Categories

LSN

3-03-489451-1



Trending On Loot